Search - tctmd.com

Displaying 281 - 300 of 428

Sort: Relevancy | Date

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Daily News

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

Todd Neale

September 19, 2019

News Daily News

MI Definitions in SCOT-HEART Prompt Outcry—Then Silence—on Twitter

Shelley Wood

September 19, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

News Daily News

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Michael O'Riordan

August 09, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

News Daily News

Rapid-Access CT Model Seeks to Increase Efficiency, Reduce Delays for Chest Pain

Yael L. Maxwell

June 21, 2019

News Daily News

Echo for Acute MI Ups Hospital Stays and Costs, Without Boosting Outcomes

Yael L. Maxwell

June 20, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

Advertisement

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

MI Definitions in SCOT-HEART Prompt Outcry—Then Silence—on Twitter

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Rapid-Access CT Model Seeks to Increase Efficiency, Reduce Delays for Chest Pain

Echo for Acute MI Ups Hospital Stays and Costs, Without Boosting Outcomes

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content